Josep Tabernero MD, PhD

Dr. Josep Tabernero holds MD and Ph.D. degrees from The Autonomous University of Barcelona, Spain. He is currently the Head of the Medical Oncology Department at the Vall d’Hebron Barcelona Hospital Campus, and Director of the Vall d’Hebron Institute of Oncology (VHIO).

He also co-directs the VHIOs Gastrointestinal and Endocrine Tumors Group and the Research Unit for Molecular Therapy of Cancer (UITM) and is Principal Investigator of several Phase I pharmacodynamic studies and translational projects with molecular targeted therapies, as well as phase II and III studies with novel chemotherapeutics.

Dr. Tabernero serves on the Editorial Boards of various top-tier journals including Annals of Oncology, ESMO Open, Cancer Discovery, and Clinical Cancer Research. He has (co) authored approximately 450 peer-reviewed papers.

He is Past-President on the Executive Board of the European Society for Medical Oncology (ESMO) having served as ESMO President 2018 – 2019. He is also a member of the American Association for Cancer Research (AACR), the American Society of Clinical Oncology (ASCO), and has been appointed as a member of several Educational and Scientific Committees of ESMO, ASCO, AACR, AACR/NCI/EORTC, ASCO Gastrointestinal, and ESMO-GI/WCGIC meetings.